TrialGut2019

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt.

Gamal Shiha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.